Tenaya Therapeutics Statistics
Total Valuation
TNYA has a market cap or net worth of $126.49 million. The enterprise value is $52.35 million.
| Market Cap | 126.49M |
| Enterprise Value | 52.35M |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TNYA has 224.23 million shares outstanding. The number of shares has increased by 73.58% in one year.
| Current Share Class | 224.23M |
| Shares Outstanding | 224.23M |
| Shares Change (YoY) | +73.58% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 0.41% |
| Owned by Institutions (%) | 21.19% |
| Float | 211.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 96.01 |
| Forward PS | 20.87 |
| PB Ratio | 1.85 |
| P/TBV Ratio | 1.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 40.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.52, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.52 |
| Quick Ratio | 4.12 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -121.86% and return on invested capital (ROIC) is -55.74%.
| Return on Equity (ROE) | -121.86% |
| Return on Assets (ROA) | -47.91% |
| Return on Invested Capital (ROIC) | -55.74% |
| Return on Capital Employed (ROCE) | -110.95% |
| Weighted Average Cost of Capital (WACC) | 19.47% |
| Revenue Per Employee | $19,071 |
| Profits Per Employee | -$1.47M |
| Employee Count | 70 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.18% in the last 52 weeks. The beta is 2.88, so TNYA's price volatility has been higher than the market average.
| Beta (5Y) | 2.88 |
| 52-Week Price Change | -65.18% |
| 50-Day Moving Average | 0.69 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 29.11 |
| Average Volume (20 Days) | 2,863,698 |
Short Selling Information
The latest short interest is 21.64 million, so 9.65% of the outstanding shares have been sold short.
| Short Interest | 21.64M |
| Short Previous Month | 20.77M |
| Short % of Shares Out | 9.65% |
| Short % of Float | 10.22% |
| Short Ratio (days to cover) | 11.68 |
Income Statement
In the last 12 months, TNYA had revenue of $1.34 million and -$103.12 million in losses. Loss per share was -$0.53.
| Revenue | 1.34M |
| Gross Profit | 1.34M |
| Operating Income | -82.68M |
| Pretax Income | -103.12M |
| Net Income | -103.12M |
| EBITDA | -75.52M |
| EBIT | -82.68M |
| Loss Per Share | -$0.53 |
Balance Sheet
The company has $78.09 million in cash and $3.95 million in debt, with a net cash position of $74.14 million or $0.33 per share.
| Cash & Cash Equivalents | 78.09M |
| Total Debt | 3.95M |
| Net Cash | 74.14M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | 69.41M |
| Book Value Per Share | 0.31 |
| Working Capital | 66.99M |
Cash Flow
In the last 12 months, operating cash flow was -$52.33 million and capital expenditures -$263,000, giving a free cash flow of -$52.59 million.
| Operating Cash Flow | -52.33M |
| Capital Expenditures | -263,000 |
| Depreciation & Amortization | 7.15M |
| Net Borrowing | n/a |
| Free Cash Flow | -52.59M |
| FCF Per Share | -$0.23 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -6,192.96% |
| Pretax Margin | -7,723.97% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TNYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -73.58% |
| Shareholder Yield | -73.58% |
| Earnings Yield | -80.45% |
| FCF Yield | -41.03% |
Analyst Forecast
The average price target for TNYA is $3.20, which is 467.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.20 |
| Price Target Difference | 467.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TNYA has an Altman Z-Score of -7.55 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.55 |
| Piotroski F-Score | 1 |